Hwang Sang Il, Kim Hyung Ook, Yoo Chang Hak, Shin Jun Ho, Son Byung Ho
Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 108 Pyung-Dong, Jongro-Ku, Seoul, 110-746, South Korea.
Surg Endosc. 2009 Jun;23(6):1252-8. doi: 10.1007/s00464-008-0140-5. Epub 2008 Oct 15.
Laparoscopic-assisted gastric surgery has become an option for the treatment of early gastric cancer. However, there are few reports of laparoscopic surgery in the management of advanced gastric cancer. In this study we describe our experience with laparoscopic-assisted distal gastrectomy (LADG) for advanced gastric cancer (AGC).
Between November 2004 and June 2007, 47 patients with AGC underwent LADG at our hospital, and 45 of those patients were enrolled in this study. These patients were compared with 83 patients who had AGC and underwent conventional open distal gastrectomy (ODG) during the same period.
Operation time was significantly longer in the LADG group than in the ODG group. Estimated blood loss in the LADG group was significantly less than in the ODG group. Time to ambulation and first flatus and duration of analgesic medication were significantly shorter in the LADG group. The morbidity and mortality rate were also lower than in the ODG group, with no statistically significant difference. The distance of the proximal resection margin showed no significant difference compared with ODG (6.3 +/- 0.9 versus 6.5 +/- 0.9 cm; p = 0.228). The mean number of nodes resected with LADG was 35.6 +/- 14.2, and that with ODG was 38.3 +/- 11.4 (p = 0.269). The mean follow-up for the LADG group was 23.6 months (range 9-40 months). In the LADG group, recurrence was observed in six patients (13.3%). Three patients had recurrence and died after 10 (IIIB), 11 (IIIA), and 13 (IIIB) months.
LADG with extended lymphadenectomy for AGC is a feasible and safe procedure and has several advantages. Moreover, this method can achieve a radical oncologic equivalent resection. Indications for LADG with extended lymphadenectomy could be expanded in the treatment of locally advanced gastric cancer.
腹腔镜辅助胃癌手术已成为早期胃癌治疗的一种选择。然而,关于腹腔镜手术治疗进展期胃癌的报道较少。在本研究中,我们描述了我们应用腹腔镜辅助远端胃癌切除术(LADG)治疗进展期胃癌(AGC)的经验。
2004年11月至2007年6月期间,我院47例AGC患者接受了LADG手术,其中45例患者纳入本研究。将这些患者与同期83例接受传统开放性远端胃癌切除术(ODG)的AGC患者进行比较。
LADG组的手术时间明显长于ODG组。LADG组的估计失血量明显少于ODG组。LADG组的下床活动时间、首次排气时间和镇痛药物使用时间明显更短。发病率和死亡率也低于ODG组,但无统计学显著差异。近端切缘距离与ODG组相比无显著差异(6.3±0.9对6.5±0.9 cm;p = 0.228)。LADG切除的平均淋巴结数为35.6±14.2,ODG为38.3±11.4(p = 0.269)。LADG组的平均随访时间为23.6个月(范围9 - 40个月)。在LADG组中,6例患者(13.3%)出现复发。3例患者分别在10(IIIB期)、11(IIIA期)和13(IIIB期)个月后复发并死亡。
LADG联合扩大淋巴结清扫术治疗AGC是一种可行且安全的手术方式,具有多种优势。此外,该方法可实现根治性肿瘤等效切除。LADG联合扩大淋巴结清扫术在局部进展期胃癌治疗中的适应证可进一步扩大。